Loading…

Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice

Intracerebral or intraperitoneal injections of brain extracts from the Alzheimer’s disease patients result in the acceleration of cerebral β-amyloidosis in transgenic mice. Earlier, we have found that intravenous injections of synthetic full-length amyloid-β (Aβ) comprising the isomerized Asp7 trigg...

Full description

Saved in:
Bibliographic Details
Published in:Neurotoxicity research 2016-05, Vol.29 (4), p.551-557
Main Authors: Kulikova, Alexandra A., Cheglakov, Ivan B., Kukharsky, Michail S., Ovchinnikov, Ruslan K., Kozin, Sergey A., Makarov, Alexander A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intracerebral or intraperitoneal injections of brain extracts from the Alzheimer’s disease patients result in the acceleration of cerebral β-amyloidosis in transgenic mice. Earlier, we have found that intravenous injections of synthetic full-length amyloid-β (Aβ) comprising the isomerized Asp7 trigger cerebral β-amyloidosis. In vitro studies have shown that isomerization of Asp7 promotes zinc-induced oligomerization of the Aβ metal-binding domain (Aβ 1–16 ). Here we report that single intracerebral injection of the peptide Aβ 1–16 with isomerized Asp7 ( iso Aβ 1–16 ) but not the injection of Aβ 1–16 significantly increases amyloid burden in 5XFAD transgenic mice. Our results provide evidence for a role of iso Aβ 1–16 as a minimal seeding agent of Aβ aggregation in vivo.
ISSN:1029-8428
1476-3524
DOI:10.1007/s12640-016-9603-y